Robinson L A
Division of Cardiovascular and Thoracic Surgery, University of South Florida College of Medicine, Tampa, USA.
Q J Nucl Med. 2001 Mar;45(1):38-46.
Radioisotope bone scanning is frequently employed in staging malignancies. However, false positive results are common, and biopsy is usually required. In the absence of plain radiographic abnormalities or local symptoms, localization of the area of abnormal tracer activity at the time of open rib or sternum biopsy may be difficult. It often requires resection of a large portion of one or more ribs or other bones to assure that the target area was biopsied, and still the area in question is commonly missed. In this setting, the newly-developed, small gamma probe is now used as a tool to allow precise intraoperative localization of increased tracer activity in the target bone. The use of gamma counting is an easy, highly accurate aid (100% sensitivity) to localize areas of abnormal radioisotope uptake in suspected asymptomatic osseous metastases, usually for open biopsy of a rib. The use of this technique obviates the need to obtain intraoperative localizing radiographs to confirm accurate rib identification, thereby substantially decreasing operative time.
放射性核素骨扫描常用于恶性肿瘤的分期。然而,假阳性结果很常见,通常需要进行活检。在没有X线平片异常或局部症状的情况下,在进行开放性肋骨或胸骨活检时,定位异常示踪剂活性区域可能很困难。通常需要切除一根或多根肋骨或其他骨头的大部分,以确保对目标区域进行了活检,但仍常常错过可疑区域。在这种情况下,新开发的小型γ探测器现在被用作一种工具,以便在术中精确地定位目标骨中示踪剂活性增加的区域。使用γ计数是一种简单、高度准确的辅助手段(灵敏度为100%),用于定位疑似无症状骨转移中放射性核素摄取异常的区域(通常用于肋骨的开放性活检)。使用这项技术无需术中拍摄定位X线片来确认肋骨的准确位置,从而大大缩短了手术时间。